> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# MedWatch to Manufacturers Program Discontinued
- URL: https://www.fdaweb.com/medwatch-to-manufacturers-program-discontinued/
- Published: 2020-08-04T12:00:00.000Z
- Updated: 2026-09-14T16:23:46.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147347

FDA says it discontinued the MedWatch to Manufacturers program as of 7/31\. Under the program, participating drug and biologic manufacturers could receive information from the agency on serious adverse event reports submitted directly to FDA for new molecular entities and original biologics for the first three years after approval, according to an online [notice](https://www.fda.gov/safety/reporting-serious-problems-fda/medwatch-manufacturer-program?ref=fdaweb.com).

FDA says it retired the program due to advancements with the FDA Adverse Event Reporting System public dashboard that give manufacturers ways to search for and organize data on adverse events reported to the agency for many human drug and biologic products.